The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atomoxetine Accord 18 mg Hard Capsules

18 milligram(s) Capsule, hard

Accord Healthcare Ireland Ltd.PA2315/019/002

Main Information

Trade NameAtomoxetine Accord 18 mg Hard Capsules
Active SubstancesAtomoxetine hydrochloride
Strength18 milligram(s)
Dosage FormCapsule, hard
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/019/002

Group Information

ATC CodeN06BA09 atomoxetine

Status

Authorised/WithdrawnAuthorised
Licence Issued14/01/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

« Back